Cargando…

Seroprevalence of SARS-CoV-2 antibodies among children and adolescents recruited in a malariometric survey in north-eastern Tanzania July 2021

BACKGROUND: African countries stand out globally as the region seemingly least affected by the COVID-19 pandemic, caused by the virus SARS-CoV-2. Besides a younger population and potential pre-existing immunity to a SARS-CoV-2-like virus, it has been hypothesized that co-infection or recent history...

Descripción completa

Detalles Bibliográficos
Autores principales: Lyimo, Eric, Fougeroux, Cyrielle, Malabeja, Anangisye, Mbwana, Joyce, Hayuma, Paul M., Liheluka, Edwin, Turner, Louise, Gesase, Samwel, Lavstsen, Thomas, Lusingu, John P. A., Minja, Daniel T. R., Wang, Christian W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652923/
https://www.ncbi.nlm.nih.gov/pubmed/36371172
http://dx.doi.org/10.1186/s12879-022-07820-6
_version_ 1784828580776116224
author Lyimo, Eric
Fougeroux, Cyrielle
Malabeja, Anangisye
Mbwana, Joyce
Hayuma, Paul M.
Liheluka, Edwin
Turner, Louise
Gesase, Samwel
Lavstsen, Thomas
Lusingu, John P. A.
Minja, Daniel T. R.
Wang, Christian W.
author_facet Lyimo, Eric
Fougeroux, Cyrielle
Malabeja, Anangisye
Mbwana, Joyce
Hayuma, Paul M.
Liheluka, Edwin
Turner, Louise
Gesase, Samwel
Lavstsen, Thomas
Lusingu, John P. A.
Minja, Daniel T. R.
Wang, Christian W.
author_sort Lyimo, Eric
collection PubMed
description BACKGROUND: African countries stand out globally as the region seemingly least affected by the COVID-19 pandemic, caused by the virus SARS-CoV-2. Besides a younger population and potential pre-existing immunity to a SARS-CoV-2-like virus, it has been hypothesized that co-infection or recent history of Plasmodium falciparum malaria may be protective of COVID-19 severity and mortality. The number of COVID-19 cases and deaths, however, may be vastly undercounted. Very little is known about the extent to which the Tanzanian population has been exposed to SARS-CoV-2. Here, we investigated the seroprevalence of IgG to SARS-CoV-2 spike protein in two Tanzanian rural communities 1½ years into the pandemic and the association of coinciding malaria infection and exposure. METHODS: During a malariometric survey in July 2021 in two villages in north-eastern Tanzania, blood samples were taken from 501 participants (0–19 years old). Malaria was detected by mRDT and microscopy. Levels of IgG against the spike protein of SARS-CoV-2 were measured by ELISA as well as IgG against five different antigens of P. falciparum; CIDRα1.1, CIDRα1.4 and CIDRα1.5 of PfEMP1 and GLURP and MSP3. RESULTS: The seroprevalence of SARS-CoV-2 IgG was 39.7% (106/267) in Kwamasimba and 32.5% (76/234) in Mkokola. In both villages the odds of being seropositive increased significantly with age (AOR = 1.12, 95% CI 1.07–1.17, p < 0.001). P. falciparum malaria prevalence by blood smear microscopy was 7.9% in Kwamasimba and 2.1% in Mkokola. 81.3% and 70.5% in Kwamasimba and Mkokola, respectively, showed recognition of minimum one malaria antigen. Residing in Kwamasimba was associated with a broader recognition (AOR = 1.91, 95% CI 1.34–2.71, p < 0.001). The recognition of malaria antigens increased significantly with age in both villages (AOR = 1.12; 95% CI 1.08–1.16, p < 0.001). Being SARS-CoV-2 seropositive did not associate with the breadth of malaria antigen recognition when adjusting for age (AOR = 0.99; 95% CI 0.83–1.18; p = 0.91). CONCLUSION: More than a third of the children and adolescents in two rural communities in Tanzania had antibodies to SARS-CoV-2. In particular, the adolescents were seropositive but being seropositive did not associate with the status of coinciding malaria infections or previous exposure. In Tanzania, natural immunity may have developed fast, potentially protecting a substantial part of the population from later variants. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-022-07820-6.
format Online
Article
Text
id pubmed-9652923
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-96529232022-11-14 Seroprevalence of SARS-CoV-2 antibodies among children and adolescents recruited in a malariometric survey in north-eastern Tanzania July 2021 Lyimo, Eric Fougeroux, Cyrielle Malabeja, Anangisye Mbwana, Joyce Hayuma, Paul M. Liheluka, Edwin Turner, Louise Gesase, Samwel Lavstsen, Thomas Lusingu, John P. A. Minja, Daniel T. R. Wang, Christian W. BMC Infect Dis Research BACKGROUND: African countries stand out globally as the region seemingly least affected by the COVID-19 pandemic, caused by the virus SARS-CoV-2. Besides a younger population and potential pre-existing immunity to a SARS-CoV-2-like virus, it has been hypothesized that co-infection or recent history of Plasmodium falciparum malaria may be protective of COVID-19 severity and mortality. The number of COVID-19 cases and deaths, however, may be vastly undercounted. Very little is known about the extent to which the Tanzanian population has been exposed to SARS-CoV-2. Here, we investigated the seroprevalence of IgG to SARS-CoV-2 spike protein in two Tanzanian rural communities 1½ years into the pandemic and the association of coinciding malaria infection and exposure. METHODS: During a malariometric survey in July 2021 in two villages in north-eastern Tanzania, blood samples were taken from 501 participants (0–19 years old). Malaria was detected by mRDT and microscopy. Levels of IgG against the spike protein of SARS-CoV-2 were measured by ELISA as well as IgG against five different antigens of P. falciparum; CIDRα1.1, CIDRα1.4 and CIDRα1.5 of PfEMP1 and GLURP and MSP3. RESULTS: The seroprevalence of SARS-CoV-2 IgG was 39.7% (106/267) in Kwamasimba and 32.5% (76/234) in Mkokola. In both villages the odds of being seropositive increased significantly with age (AOR = 1.12, 95% CI 1.07–1.17, p < 0.001). P. falciparum malaria prevalence by blood smear microscopy was 7.9% in Kwamasimba and 2.1% in Mkokola. 81.3% and 70.5% in Kwamasimba and Mkokola, respectively, showed recognition of minimum one malaria antigen. Residing in Kwamasimba was associated with a broader recognition (AOR = 1.91, 95% CI 1.34–2.71, p < 0.001). The recognition of malaria antigens increased significantly with age in both villages (AOR = 1.12; 95% CI 1.08–1.16, p < 0.001). Being SARS-CoV-2 seropositive did not associate with the breadth of malaria antigen recognition when adjusting for age (AOR = 0.99; 95% CI 0.83–1.18; p = 0.91). CONCLUSION: More than a third of the children and adolescents in two rural communities in Tanzania had antibodies to SARS-CoV-2. In particular, the adolescents were seropositive but being seropositive did not associate with the status of coinciding malaria infections or previous exposure. In Tanzania, natural immunity may have developed fast, potentially protecting a substantial part of the population from later variants. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-022-07820-6. BioMed Central 2022-11-12 /pmc/articles/PMC9652923/ /pubmed/36371172 http://dx.doi.org/10.1186/s12879-022-07820-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Lyimo, Eric
Fougeroux, Cyrielle
Malabeja, Anangisye
Mbwana, Joyce
Hayuma, Paul M.
Liheluka, Edwin
Turner, Louise
Gesase, Samwel
Lavstsen, Thomas
Lusingu, John P. A.
Minja, Daniel T. R.
Wang, Christian W.
Seroprevalence of SARS-CoV-2 antibodies among children and adolescents recruited in a malariometric survey in north-eastern Tanzania July 2021
title Seroprevalence of SARS-CoV-2 antibodies among children and adolescents recruited in a malariometric survey in north-eastern Tanzania July 2021
title_full Seroprevalence of SARS-CoV-2 antibodies among children and adolescents recruited in a malariometric survey in north-eastern Tanzania July 2021
title_fullStr Seroprevalence of SARS-CoV-2 antibodies among children and adolescents recruited in a malariometric survey in north-eastern Tanzania July 2021
title_full_unstemmed Seroprevalence of SARS-CoV-2 antibodies among children and adolescents recruited in a malariometric survey in north-eastern Tanzania July 2021
title_short Seroprevalence of SARS-CoV-2 antibodies among children and adolescents recruited in a malariometric survey in north-eastern Tanzania July 2021
title_sort seroprevalence of sars-cov-2 antibodies among children and adolescents recruited in a malariometric survey in north-eastern tanzania july 2021
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652923/
https://www.ncbi.nlm.nih.gov/pubmed/36371172
http://dx.doi.org/10.1186/s12879-022-07820-6
work_keys_str_mv AT lyimoeric seroprevalenceofsarscov2antibodiesamongchildrenandadolescentsrecruitedinamalariometricsurveyinnortheasterntanzaniajuly2021
AT fougerouxcyrielle seroprevalenceofsarscov2antibodiesamongchildrenandadolescentsrecruitedinamalariometricsurveyinnortheasterntanzaniajuly2021
AT malabejaanangisye seroprevalenceofsarscov2antibodiesamongchildrenandadolescentsrecruitedinamalariometricsurveyinnortheasterntanzaniajuly2021
AT mbwanajoyce seroprevalenceofsarscov2antibodiesamongchildrenandadolescentsrecruitedinamalariometricsurveyinnortheasterntanzaniajuly2021
AT hayumapaulm seroprevalenceofsarscov2antibodiesamongchildrenandadolescentsrecruitedinamalariometricsurveyinnortheasterntanzaniajuly2021
AT lihelukaedwin seroprevalenceofsarscov2antibodiesamongchildrenandadolescentsrecruitedinamalariometricsurveyinnortheasterntanzaniajuly2021
AT turnerlouise seroprevalenceofsarscov2antibodiesamongchildrenandadolescentsrecruitedinamalariometricsurveyinnortheasterntanzaniajuly2021
AT gesasesamwel seroprevalenceofsarscov2antibodiesamongchildrenandadolescentsrecruitedinamalariometricsurveyinnortheasterntanzaniajuly2021
AT lavstsenthomas seroprevalenceofsarscov2antibodiesamongchildrenandadolescentsrecruitedinamalariometricsurveyinnortheasterntanzaniajuly2021
AT lusingujohnpa seroprevalenceofsarscov2antibodiesamongchildrenandadolescentsrecruitedinamalariometricsurveyinnortheasterntanzaniajuly2021
AT minjadanieltr seroprevalenceofsarscov2antibodiesamongchildrenandadolescentsrecruitedinamalariometricsurveyinnortheasterntanzaniajuly2021
AT wangchristianw seroprevalenceofsarscov2antibodiesamongchildrenandadolescentsrecruitedinamalariometricsurveyinnortheasterntanzaniajuly2021